Authors: GILLETTE JF FERME C MOISY N MIGNOT L SCHACH R VIGNAUX JR BESNER JG CAILLE G BELPOMME D

Citation: Jf. Gillette et al., DOUBLE-BLIND CROSSOVER CLINICAL AND PHARMACOKINETIC COMPARISON OF ORAL MORPHINE SYRUP AND SUSTAINED-RELEASE MORPHINE-SULFATE CAPSULES IN PATIENTS WITH CANCER-RELATED PAIN, Clinical drug investigation, 14, 1997, pp. 22-27

Authors: KRAKOWSKI I GESTIN Y JAULMES F LAKDJA F MEYNADIER J POULAIN P DIBORGO CP REBATTU P SCHACH R GOLDBERG J BOUREAU F FALCOFF H GUILLAIN H LARUE F MAGNET M SALAMAGNE M SERRIE A TRECHOT P VERDIE JC

Citation: I. Krakowski et al., RECOMMENDATIONS FOR GOOD PRACTICE IN THE MANAGEMENT OF CANCER PAIN INTHE ADULT AND THE CHILD, Bulletin du cancer, 83, 1996, pp. 9-81

Authors: KRAKOWSKI I FALCOFF H GESTIN Y GOLDBERG J GUILLAIN H JAULMES F LAKDJA F LARUE F MAGNET M MEYNADIER J POULAIN P DIBORGO CP REBATTU P SALAMAGNE M SERRIE A SCHACH R TRECHOT P VERDIE JC

Citation: I. Krakowski et al., GUIDELINES FOR MANAGEMENT OF CANCER PAIN IN CHILDREN AND ADULTS, Bulletin du cancer, 82, 1995, pp. 245-315

Authors: FRICKER JP KHER A VERGNES Y HEITZ A SCHACH R RODIER JF JANSER JC

Citation: Jp. Fricker et al., 10 DAYS OR 20 DAYS PROPHYLAXIS OF VENOUS THROMBOEMBOLISM IN ONCOLOGICAL SURGERY BY A LOW-MOLECULAR-WEIGHT HEPARIN (FRAGMIN-R), Thrombosis and haemostasis, 69(6), 1993, pp. 1113-1113